PrepX is an AI-powered platform for practicing English tests like PTE, IELTS, and more. Improve your skills with personalized exercises, instant feedback, and comprehensive study resources.

HIV pre‐exposure prophylaxis (PrEP), the use of HIV treatment medication by people at risk of HIV to reduce their risk of acquisition, has emerged over recent years as a highly‐effe­ctive HIV prevention tool.

May 22, 2017 · PrEPX is a population-based HIV prevention study examining how expanding the use of PrEP* medication impacts the rates of new HIV infections in Victoria. “It is important that people …

WHO defines pre-exposure prophylaxis (PrEP) as the use of oral tenofovir disoproxil fumarate (TDF) or co-formulated TDF/emtricitabine (TDF/FTC) or co-formulated TDF/lamivudine (TDF/3TC) by HIV …

Jul 26, 2016 · The PrEPX Study enrolled over 5,000 participants between 2016 and 2018 in Victoria, South Australia and Tasmania. Participants were at risk of HIV infections and received daily …

Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV transmission in people at high risk of HIV acquisition. PrEP is highly efficacious when taken either …

This study evaluated whether PREPX eligibility criteria correlated with biological HIV risk markers—namely, syphilis, anorectal chlamydia, or anorectal gonorrhea (sexually transmitted …

May 29, 2018 · PrEPX is a prospective, population-level intervention study, designed to emulate “real world” conditions to reflect the likely clinical scenario were tenofovir and emtricitabine to become …

Evaluation of preexposure (PrEP) eligibility criteria, using sexually transmissible infections as markers of human immunodeficiency virus (HIV) risk at enrollment in PrEPX, a large Australian HIV PrEP trial.

PrEP involves the use of HIV medications (co-formulated tenofovir disoproxil with emtricitabine [TD/FTC]) by people who are HIV negative to reduce their risk of HIV from potential exposure in the …